Financial reports
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
18 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
14 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Feb 24
8-K
Bankruptcy or Receivership
2 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
23 Jan 24
8-K
MedAvail Receives Nasdaq Notification of Non-Compliance Related
17 Nov 23
8-K
Other Events
14 Nov 23
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
18 Aug 23
8-K
MedAvail Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
MedAvail Announces 1-for-50 Reverse Stock Split
31 Jul 23
8-K
Other Events
29 Jun 23
8-K
Changes in Registrant's Certifying Accountant
16 Jun 23
Registration and prospectus
25-NSE
Exchange delisting
21 Mar 24
S-3/A
Shelf registration (amended)
14 Jul 23
S-8
Registration of securities for employees
29 Jun 23
S-3
Shelf registration
29 Jun 23
POS AM
Prospectus update (post-effective amendment)
14 Oct 22
424B5
Prospectus supplement for primary offering
26 Aug 22
424B3
Prospectus supplement
26 Aug 22
S-3
Shelf registration
12 Aug 22
S-3
Shelf registration
12 Aug 22
424B3
Prospectus supplement
24 Jun 22
Proxies
DEFA14A
Additional proxy soliciting materials
19 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
PRE 14A
Preliminary proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
PRE 14A
Preliminary proxy
21 Apr 22
DEF 14A
Definitive proxy
30 Apr 21
DEF 14A
Definitive proxy
5 Dec 19
PRE 14A
Preliminary proxy
25 Nov 19
Other
EFFECT
Notice of effectiveness
20 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
UPLOAD
Letter from SEC
10 Jul 23
EFFECT
Notice of effectiveness
21 Oct 22
EFFECT
Notice of effectiveness
29 Aug 22
EFFECT
Notice of effectiveness
29 Aug 22
CORRESP
Correspondence with SEC
24 Aug 22
CORRESP
Correspondence with SEC
24 Aug 22
UPLOAD
Letter from SEC
18 Aug 22
UPLOAD
Letter from SEC
18 Aug 22
Ownership
SC 13G/A
Alyeska Investment Group, L.P.
14 Feb 24
4
Robert C. Faulkner
6 Feb 24
SC 13D/A
Redmile Group, LLC
6 Feb 24
4
Ramona Seabaugh
2 Oct 23
4
Mark Edward Doerr
21 Aug 23
4
Ramona Seabaugh
21 Aug 23
4
Jeremy Green
21 Jun 23
SC 13D/A
Redmile Group, LLC
21 Jun 23
SC 13D/A
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
21 Jun 23
4
Fan Yu
21 Jun 23